BioMall
Brand Store/abm good/Immortalized Human Cranial Periosteal Cells (Tag58)
I
GENERAL CATALOGUE

Immortalized Human Cranial Periosteal Cells (Tag58)

T0716 · 1 x 106 cells / 1.0 mL

abm good · Cat: T0716

Reach 3+ verified distributors

Catalog No: T0716
Category: Cellular Materials
Pack Size: 1 x 106 cells / 1.0 mL
Brand: abm good

Description

The Immortalized Human Cranial Periosteal Cell Line TAg58 is the first human cranial periosteal cell line isolated from a healthy adult patient biopsy and immortalized by lentiviral transduction with the large SV40 T antigen. The following are key characteristics that have been observed for the Immortalized Human Cranial Periosteal Cell Line TAg58 Alexander et al., 2015 : Maintains long-term cell proliferation and osteogenic differentiation potential Shows stronger calcium phosphate mineralization than parental primary cells Maintains similar expression patterns for most surface antigens as parental primary cells Expresses higher levels of stem cell surface markers, CD146, and MSCA-1 mesenchymal stem cell antigen-1 , as well as higher constitutive mRNA levels of key osteogenesis factors e.g. Osteocalcin, alkaline phosphatase, runx-2 compared to parental primary cells The Immortalized Human Cranial Periosteal Cell Line TAg58 represents a suitable experimental platform for studying periosteal cell biology, bone formation, and bone regeneration. Depositor Profile: Prof. Dr. Dorothea Alexander-Friedrich, University Hospital Tubingen In Germany alone, more than 10,000 people are newly diagnosed with oral cancer every year resulting in tumor and in the most cases jaw bone resection. In order to reconstruct the resulting bone defects, an alternative to autologous bone transplantation is needed. The research laboratory of the Department of Oral and Maxillofacial Surgery of the University Hospital Tubingen focuses its research on the field of bone tissue engineering TE . Read how their work with jaw and cranial periosteal cells translate into the generation of 3D TE-constructs and lead the way to biocompatible stem cell-based therapies. Read full profile. Characterization by osteogenic differentiation experiments, Western blot, flow cytometry, detection of cell mineralization by fluorescent osteoImage staining, and gene expression analysis.

More from abm good

CTRC CRISPR Knockout 293T Cell Line
CTRC CRISPR Knockout 293T Cell Line
T3004362
Cellular Materials
Recombinant Human MIA (E. coli)
Recombinant Human MIA (E. coli)
Z102049
Cellular Materials
Scrambled (spCas9) Negative Control HCC-LM3 Cell Line
Scrambled (spCas9) Negative Control HCC-LM3 Cell Line
T9744
Cellular Materials
PriGrow X Series Medium for T0431
PriGrow X Series Medium for T0431
TM0431
Cellular Materials
Recombinant Human BAFF-R (TNFRSF13C) (E. coli)
Recombinant Human BAFF-R (TNFRSF13C) (E. coli)
Z100017
Cellular Materials
FAM134B CRISPR Knockout 293T Cell Line
FAM134B CRISPR Knockout 293T Cell Line
T3006027
Cellular Materials
CCDC57 CRISPR Knockout 293T Cell Line
CCDC57 CRISPR Knockout 293T Cell Line
T3003004
Cellular Materials
C4orf39 CRISPR Knockout 293T Cell Line
C4orf39 CRISPR Knockout 293T Cell Line
T3006164
Cellular Materials